Bio-Techne Corp. TECH recently launched an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to value ...

近期，Bio-Techne Corp（NASDAQ:TECH）董事Amy E. Herr进行了一笔股票交易。在2025年2月14日，她以平均每股$65.96的价格出售了总值$122,690的股票。此次交易后，Herr在公司的直接持股量为1,040股。根据 InvestingPro 数据显示，该公司股票目前接近52周低点$61.16，分析师给出的目标价区间为$75至$95。

Chicago, for ‘The Bear,’ is depicted — accurately — as a place where the goal is not necessarily to win status or acclaim so ...

(RTTNews) - Bio-Techne (TECH), a US-based biotechnology company Thursday has introduced an expanded range of human and mouse RNAscope in situ hybridization probes to support spatial biology ...

Baird R W lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a strong-buy rating to a hold rating in a research note published on Wednesday morning,Zacks.com reports. Several other research ...

MINNEAPOLIS, Feb. 20, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope ...

Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology research and the development of next-generation ...

Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools, is pleased to announce the official release of GMP Transposase mRNA for the TcBuster™ non-viral ...

Support from Generation X and Baby Boomers has put Nigel Farage’s Reform UK at the top of the Techne UK tracker poll for the first time ever this week ...

Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance ...